LONGBOARD PHARMACEUTICALS IN's ticker is LBPH and the CUSIP is 54300N103. A total of 20 filers reported holding LONGBOARD PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $95,371 | +2216.5% | 17,153 | -98.4% | 0.00% | -100.0% |
| Q1 2023 | $4,117 | +31.9% | 1,047,705 | +6.1% | 0.00% | 0.0% |
| Q4 2022 | $3,121 | -99.9% | 987,712 | -6.3% | 0.00% | 0.0% |
| Q3 2022 | $3,923,000 | +21.7% | 1,054,559 | +1.1% | 0.00% | 0.0% |
| Q2 2022 | $3,224,000 | -40.6% | 1,043,216 | -0.3% | 0.00% | -33.3% |
| Q1 2022 | $5,428,000 | +397.1% | 1,045,929 | +363.7% | 0.00% | +200.0% |
| Q4 2021 | $1,092,000 | +119.7% | 225,557 | +314.3% | 0.00% | – |
| Q2 2021 | $497,000 | -84.0% | 54,443 | -71.4% | 0.00% | -100.0% |
| Q1 2021 | $3,106,000 | – | 190,349 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,273,221 | $11,069,000 | 0.66% |
| Integral Health Asset Management, LLC | 30,000 | $146,000 | 0.04% |
| FARALLON CAPITAL MANAGEMENT LLC | 810,500 | $3,923,000 | 0.02% |
| Orbimed Advisors | 113,500 | $554,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 70,000 | $339,000 | 0.01% |
| Alyeska Investment Group, L.P. | 62,500 | $305,000 | 0.00% |
| Veritable, L.P. | 20,534 | $100,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 225,557 | $1,092,000 | 0.00% |
| FMR LLC | 1,515,583 | $7,336,000 | 0.00% |
| CITIGROUP INC | 200,000 | $968,000 | 0.00% |